| 1 |
Vigilance on imported cosmetics products sold in the domestic market without valid lmport Registration certificate |
2026-Jul-23 |
|
255 KB |
| 2 |
Clarification regarding submission of applications under Rule 4 of the Drugs and Cosmetics (Compounding of Offences) Rules, 2025. |
2026-Jul-22 |
|
67 KB |
| 3 |
Inviting comments on consideration of the proposal regarding Issue of use of brand name extensions by the pharmaceutical firms |
2026-Jul-06 |
|
53 KB |
| 4 |
Submission of Post Approval Changes Applications of Registration Certificate and Import Licence of Human Vaccines and Anti-sera through SUGAM Portal |
2026-Jun-24 |
|
477 KB |
| 5 |
Regulation of Formulation intermediates such as Directly Compressible granules, Taste masked granules, Modified release granules / Pellets |
2026-Jun-24 |
|
758 KB |
| 6 |
Sale of In-Vitro Fertilization media, reagents and related consumables used in Assisted Reproductive Technology procedures |
2026-Jun-24 |
|
323 KB |
| 7 |
Constitution of Consultancy Committee of Key Stakeholders for Advice on Suo-Motu Disclosure under Section 4 of the RTI Act, 2005 in CDSCO |
2026-Jun-16 |
|
134 KB |
| 8 |
Submission of Compliance for lmported/manufactured Hair Color Cosmetics Products as per Cosmetics Rules, 2020 and applicable BIS Standards |
2026-Jun-11 |
|
350 KB |
| 9 |
Implementation of Pharmacovigilance (PV) System as per the requirement of Schedule M of Drugs & Cosmetics Act 1940 and the Rules made there under |
2026-Jun-03 |
|
316 KB |
| 10 |
Transfer List 2025 |
2026-Jun-03 |
|
653 KB |
